From stuff.co.nz?..
It had to happen sooner or later. After a 13-year hiatus in the approval of drugs to help reduce obesity, a couple of weight-loss pills recently got the nod from the United States Food and Drug Administration (FDA), albeit with a few caveats to make sure that these are heart-safe, unlike some previous offerings.
Arena Pharmaceuticals? Belviq broke the ice, getting approval from the FDA in late June, with Vivus Inc?s Qsymia securing the okay a few weeks later. Vivus claims that obese people who take the drug can look forward to losing about 10 per cent of their body weight after 12 months, which is a lot of weight if you?re obese.
Qsymia is a combination of two drugs, an anti-seizure medication and an appetite suppressant, which together work their magic. Yet just two years ago, this same drug was assessed by the FDA under its previous name, Qnexa. Approval wasn?t granted then because the side effects ? confusion, memory loss, birth defects, increased heart rate, kidney stones ? were deemed too dangerous. But the FDA has now granted approval to the same drug because the side effects of obesity are perceived to be far worse. Gawd!
Just read that list of side effects again to get some idea of the desperate state in which the FDA finds itself.
To read the full story?..Click here
Source: http://www.lensaunders.com/wp/?p=2919
patriots broncos game saints willis mcgahee willis mcgahee ship aground off italy nfl playoff schedule 2012 nfl live
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.